Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Cancer Research
|
January 18, 2008
Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling
Likun Li, ElMoataz Abdel Fattah, Guangwen Cao, et al.
Current Drug Targets
|
March 20, 2003
Therapeutic targets for metastatic prostate cancer
Terry L Timme, Takefumi Satoh, Salahaldin A Tahir, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 14, 2006
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients
Tetsuo Fujita, Bin S Teh, Terry L Timme, et al.
Urologic Oncology
|
February 26, 2013
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models
Tetsuo Fujita, Takefumi Satoh, Terry L Timme, et al.
Molecular Cancer Research : MCR
|
September 10, 2009
Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression
Masami Watanabe, Guang Yang, Guangwen Cao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2004
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients
Takefumi Satoh, Bin S Teh, Terry L Timme, et al.
The American Journal of Pathology
|
March 26, 2003
Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis
Guangwen Cao, Guang Yang, Terry L Timme, et al.
Technology in Cancer Research & Treatment
|
January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer
Michael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2004
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data
Bin S Teh, Gustavo Ayala, Laura Aguilar, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Cancer Research
|
January 18, 2008
Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling
Likun Li, ElMoataz Abdel Fattah, Guangwen Cao, et al.
Current Drug Targets
|
March 20, 2003
Therapeutic targets for metastatic prostate cancer
Terry L Timme, Takefumi Satoh, Salahaldin A Tahir, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 14, 2006
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients
Tetsuo Fujita, Bin S Teh, Terry L Timme, et al.
Urologic Oncology
|
February 26, 2013
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models
Tetsuo Fujita, Takefumi Satoh, Terry L Timme, et al.
Molecular Cancer Research : MCR
|
September 10, 2009
Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression
Masami Watanabe, Guang Yang, Guangwen Cao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2004
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients
Takefumi Satoh, Bin S Teh, Terry L Timme, et al.
The American Journal of Pathology
|
March 26, 2003
Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis
Guangwen Cao, Guang Yang, Terry L Timme, et al.
Technology in Cancer Research & Treatment
|
January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer
Michael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2004
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data
Bin S Teh, Gustavo Ayala, Laura Aguilar, et al.
Page
of 2